We are live on ! Find out more
AXDX

Accelerate Diagnostics

Delisted

AXDX was delisted on the 14th of May, 2025.

86 hedge funds and large institutions have $400M invested in Accelerate Diagnostics in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 27 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 4

26% more capital invested

Capital invested by funds: $317M → $400M (+$82.6M)

15% more funds holding

Funds holding: 7586 (+11)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less call options, than puts

Call options by funds: $1.78M | Put options by funds: $1.87M

15% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 27

Holders
86
Holders Change
+11
Holders Change %
+14.67%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
15
Increased
23
Reduced
27
Closed
4
Calls
$1.78M
Puts
$1.87M
Net Calls
-$91K
Net Calls Change
+$2.92M

AXDX Hedge Fund Activity: Q2 2015 in Review

86 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q2 2015, worth a combined $400M — up 26% from $317M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AXDX positions and 4 closed out — a net gain of 11 holders — while 23 added to existing stakes and 27 trimmed.

The largest buyer was Cannell & Co, opening a new position worth an estimated $24.3M. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.55M.

  • 86 institutional investors held Accelerate Diagnostics (AXDX) as of Q2 2015, up from 75 in Q1 2015.
  • Funds reported $400M of Accelerate Diagnostics stock for Q2 2015, up 26% quarter-over-quarter.
  • 15 funds opened new Accelerate Diagnostics positions in Q2 2015 and 4 closed out, a net change of +11 holders.
  • The largest Accelerate Diagnostics buyer in Q2 2015 was Cannell & Co, an estimated $24.3M added.
  • The largest Accelerate Diagnostics seller in Q2 2015 was BlackRock Fund Advisors, an estimated $1.55M sold.

Based on aggregated 13F filings for Q2 2015.